Article
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.
Molecular cancer - 30 Aug 2017
Khemlina Galina, Ikeda Sadakatsu, Kurzrock Razelle
Abstract excerpt
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading cause of cancer-related death worldwide. It is highly refractory to most systemic therapies. Recently, significant progress has been made in uncovering genomic alterations in HCC, including potentially targetable aberrations. The most common molecular anomalies in this malignancy are mutations in the TERT promoter, TP53,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
